ESC 365 - The impact of outpatient pharmacological optimization on echocardiographic parameters in heart failure with reduced ejection fraction

ESC Professional Premium Access

The impact of outpatient pharmacological optimization on echocardiographic parameters in heart failure with reduced ejection fraction

Session: Pharmacological therapy in heart failure (2)

Topic: Pharmacotherapy

Speaker: Mr A. Pandey (CA)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mr Ashok Pandey

(Canada)

0 follower

6 more presentations in this session

Initiation, titration, and discontinuation - utilization of heart failure medicines in England (EVOLUTION HF UK)

Speaker: Doctor R. Zhang (London, GB)

Statin and risk of dementia in patients with heart failure

Speaker: Mrs Q. Ren (Hong Kong, HK)

Soluble guanylate cyclase in heart failure: A network meta-analysis and subgroup analyses of reduced and preserved ejection fraction.

Speaker: Doctor M. Ibrahim (Flint, US)

Feasibility, efficacy and safety of early and rapid initiation of evidence-based treatment for patients with HFrEF- a real world experience of the "four drugs in four weeks" strategy

Speaker: Doctor S. Sze (Leicester, GB)

Impact of pharmacological treatment for heart failure after myocardial recovery in arrhythmia-induced cardiomyopathy.

Speaker: Mr L. Dominguez Rodriguez (Vigo, ES)

Access the full session

Pharmacological therapy in heart failure (2)

Speakers: Mr A. Pandey, Doctor R. Zhang, Mrs Q. Ren, Doctor M. Ibrahim, Doctor S. Sze...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources